Table I. Demographic characteristics of the patients.

Patient Diagnosis	Gender	Age (y)	Pretransplant PRA		HLA Mismatch	C3d (Positive Ratio)	MAC (Positive Ratio)	Treatment
			Class I	Class II
DGF-1	Male	47	0	0	4/6	10/11	9/11	T+M+P
DGF-2	Female	58	0	0	4/6	7/9	7/9	C+M+P
DGF-3	Male	54	0	0	5/6	5/9	4/9	C+M+P
AR-1	Male	28	0	0	1/6	8/13	10/13	C+M+P
AR-2	Male	30	0	0	2/6	4/10	5/10	T+M+P
AR-3	Male	38	0	0	0/6	8/15	7/15	T+M+P
AR-4	Female	46	0	0	2/6	1/9	3/9	T+M+P
AR-5	Male	47	0	0	4/6	1/12	1/12	T+M+P
AR-6	Female	40	0	0	1/6	3/8	2/8	T+M+P
AR-7	Female	32	0	0	3/6	N/A	N/A	T+M+P
CR-1	Male	24	0	0	2/6	7/11	4/11	T+M+P
CR-2	Male	27	0	0	2/6	1/12	2/12	T+M+P

C, cyclosporine; C3d or MAC (positive ratio), the number of glomeruli with positive C3d or MAC staining in total observed glomeruli; M, mycophenolate mofetil; P, prednisolone; PRA, Panel reactive Ab; T, Tacrolimus.